Figure 1From: Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s diseaseRadio-HPLC data of purified [18F]-7B spiked with an unlabeled counterpart (7A) for characterization of the radiotracer (7B).Back to article page